Registry of patients with both cerebral and coronary atherosclerosis after acute ischemic stroke

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Coexistence of Cerebral and Coronary Atherosclerosis in Acute Ischemic Cerebrovascular Disease Patients Registry (CoCCA) is an observational registry focused on patients hospitalized for acute ischemic cerebrovascular disease (AICVD) who exhibit atherosclerotic changes in both cerebral and coronary arteries. This single-center study aims to identify risk factors and develop prognostic models to improve patient outcomes. Clinical, imaging, and laboratory data will be collected at baseline, with follow-up assessments conducted over five years through patient self-reports and investigator follow-ups. The goal is to enhance diagnostic and therapeutic strategies for this high-risk patient population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Diagnosed as ischemic stroke or transient ischemic attack (TIA).
2. Less than 30 days after onset of ischemic stroke or TIA symptoms.
3. Extracranial or intracranial cerebral atherosclerosis confirmed by vascular ultrasound or CT angiograpgy or MR angiograpgy or digital substraction angiography.
4. Coronary atherosclerosis confirmed by CT angiograpgy or MR angiograpgy or digital substraction angiography; or with myocardial ischemia symptoms confirmed using electrocardiogram or echocardiography or cardiac MR; or with a history of percutaneous coronary intervention or coronary artery bypass graft.

Exclusion Criteria:

1. With malignant tumors or poor organ functions or hematologic diseases, whose estimated life expectancy is less than 5 years.
2. Patients refuse to participate in the research.

Where it's running

• Xuanwu Hospital, Capital Medical University
  Beijing, Bj, China Recruiting

Study contacts

• Study coordinator: Xin Ma, MD, PhD
• Email: maxin118@hotmail.com
• Phone: 13501390691

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using artificial intelligence to predict ischemic cerebrovascular disease early

  This study is testing whether a new artificial intelligence tool can help doctors find patients at risk of serious strokes by looking at their health data.

  Recruiting Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06978348

• New biomarkers for ischemic cerebrovascular disease

  This study will test whether specific blood, cerebrospinal fluid, urine, and stool biomarkers can help diagnose and predict outcomes for people with ischemic stroke and related cerebrovascular conditions.

  Recruiting Tongji Hospital · Wuhan, Hubei and 1 other locations · NCT06890702

• Evaluating the effects of Calculus Bovis Sativus for ischemic cerebrovascular diseases

  This study is testing whether a traditional Chinese medicine called Calculus Bovis Sativus can help improve brain health and reduce inflammation in people with ischemic cerebrovascular diseases like stroke.

  Recruiting at 2 sites Tongji Hospital · Wuhan, Hubei and 1 other locations · NCT06474507

• Prognosis prediction for patients with cardiovascular and cerebrovascular diseases using multi-omics

  This study is trying to find out how different biological factors affect people with heart and brain blood vessel diseases to help doctors predict outcomes and personalize treatments for them.

  Recruiting First Affiliated Hospital Xi'an Jiaotong University · Xi'an, Shaanxi · NCT06001073

• Examining blood pressure variability in non-hypertensive patients with ischemic cerebrovascular disease

  This study looks at how changes in blood pressure over time affect non-hypertensive patients with ischemic cerebrovascular disease to see if it can help predict their risk of future health problems.

  Recruiting Xuanwu Hospital, Beijing · Beijing, BJ · NCT05232240

• Inhaled nitric oxide during mechanical clot removal for acute ischemic stroke

  This test gives inhaled nitric oxide during mechanical clot removal to adults with acute ischemic stroke to see if it is safe and can help protect vulnerable brain tissue.

  Recruiting at 2 sites Phase 1 Wake Forest University Health Sciences · Charlotte, North Carolina and 1 other locations · NCT05871606

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.